Behavioral Pharmacology of Drug Abuse: Current Status

Erscheinungsjahr 2022
ISBN: 978-0-323-91526-7
Verlag: William Andrew Publishing

Buch, Englisch, 456 Seiten, Format (B × H): 152 mm x 229 mm, Gewicht: 860 g

Behavioral Pharmacology of Drug Abuse: Current Status, Volume 93 provides an update on our current understanding of animal and human behavioral pharmacology in major classes of drugs of abuse, including nicotine, alcohol, opioids, psychostimulants, and hallucinogens, drug-environment interactions, neurochemical mechanisms and medications developments. This volume updates the field of behavioral pharmacology based on new knowledge gained in the past decade.

Zielgruppe

<p>Pharmacologists, medicinal chemists and graduate students who are interested in behavioral neuropharmacology of drug abuse.</p>

Autoren/Hrsg.

Weitere Mitwirkende

Li, Jun-Xu

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Pharmakologie, Toxikologie

Inhaltsverzeichnis

Preface Jun-Xu Li 1. Interactions between opioids and stimulants: Behavioral pharmacology of abuse-related effects David R. Maguire and Vanessa Minervini 2. In vitro and in vivo pharmacology of kratom Takato Hiranita, Samuel Obeng, Abhisheak Sharma, Jenny L. Wilkerson, Christopher R. McCurdy and Lance R. McMahon 3. Human behavioral pharmacology of stimulant drugs: An update and narrative review Ashley Strzelecki, Jessica Weafer and William W. Stoops 4. Human behavioral pharmacology of psychedelics Justin C. Strickland and Matthew W. Johnson 5. Stimulus functions of nicotine Mark G. LeSage 6. The incentive amplifying effects of nicotine: Roles in alcohol seeking and consumption Christopher P. King and Paul J. Meyer 7. Environmental influence on the preclinical evaluation of substance use disorder therapeutics Matthew L. Banks 8. Examining the effects of psychoactive drugs on complex behavioral processes in laboratory animals Brian D. Kangas 9. Receptor mechanisms underlying the CNS effects of cannabinoids: Beyond the CB1 receptor Briana Hempel and Zheng-Xiong Xi 10. Potential therapeutic targets for the treatment of opioid abuse and pain Norikazu Kiguchi and Mei-Chuan Ko 11. Trace amine-associated receptor 1 and drug abuse Ruyan Wu, Jianfeng Liu and Jun-Xu Li 12. Substance abuse and neurotransmission Sarah Davis and Jun Zhu

Über Autor(innen)

Li, Jun-Xu
Jun-Xu Li received his MD degree at Binzhou Medical University in 2o0o; In 2005 he received his Ph.D in pharmacology at Peking University. He received his postdoctoral training between 2005-2010 at the University of Texas Health Science Center at San Antonio. In 2010 he joined the faculty of Department of Pharmacology and Toxicology at the State University of New York at Buffalo and is currently a professor in the same department. He has authored more than 120 papers and is currently an associate editor of Pharmacology & Therapeutics. He serves as an reviewer for numerous scientific journals and several grant agencies. He is the past chair of Behavioral Pharmacology Division of American Society of Pharmacology and Experimental Therapeutics (ASPET) and Upstate New York Pharmacology Society. He received several awards including the Joseph Cochin Young Investigator Award from the College on Problems of Drug Dependence and the JH Woods Early Career Award in Behavioral Pharmacology from ASPET.